Resumo

BLANCO, Victor M.; ARISTIZABAL-HENAO, Natalia; AGUILAR-LONDONO, Carolina  e  TORRES-GRAJALES, José Luis. Thyroid and COVID-19. Review and recommendations for patients with thyroid disease. CES Med. [online]. 2020, vol.34, n.spe, pp.78-85.  Epub 31-Ago-2021. ISSN 0120-8705.  https://doi.org/10.21615/cesmedicina.34.covid-19.11.

Both benign and malignant thyroid diseases are highly prevalent worldwide, so it is highly likely that during the COVID-19 pandemic we will see patients with this comorbidity. This requires knowledge of the potential implications of this new virus in the functioning of the gland, the usual treatments for these diseases and special recommendations in this population. To date, there is no evidence to support that thyroid diseases increase the risk of infection or the disease severity. However, it is possible that during severe SARS-CoV-2 infections in people with or without history of thyroid disease, the thyroid tests may be altered, although transitory and does not require specific treatment. It is essential for patients to continue with their outpatient treatments and defer as far as possible surgical procedures or administration of radioactive iodine until it is considered safe to perform.

Palavras-chave : COVID-19; SARS-CoV-2; Hypothyroidism; Hyperthyroidism; Thyroid cancer.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )